Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal

Lupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution

Ruchika Sharma17 Aug 2024 11:33 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...

Sun Pharma Names Sana Shaikh as Head of Marketing

Sun Pharma to buy over 5 percent stake in Pharmazz for up to USD 15 million

Ruchika Sharma17 Aug 2024 10:00 AM IST

Mumbai: Sun Pharmaceutical Industries Limited has entered into an agreement with Pharmazz Inc. Delaware US, pursuant to which the Company has...

Wanbury ropes in Prakash Venkatraman as President of API business

Ruchika Sharma16 Aug 2024 3:53 PM IST

Mumbai: Wanbury Limited has announced the appointment of Prakash Venkatraman as President of the API business. With a stellar career...

Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMR

ICMR, Panacea Biotec begin first ever Phase 3 clinical trial for dengue vaccine in India

Ruchika Sharma16 Aug 2024 2:54 PM IST

New Delhi: The Indian Council of Medical Research (ICMR) and Panacea Biotec have announced the initiation of the first-ever Phase 3 clinical trial for...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

AstraZeneca Imfinzi gets USFDA priority review for limited-stage small cell lung cancer

Ruchika Sharma16 Aug 2024 12:30 PM IST

Cambridge: AstraZeneca's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), based on the results from the positive...

Strides Pharma Science arm New York facility gets 4 USFDA observations

USFDA issues warning letter to Aurobindo Pharma arm Unit III

Ruchika Sharma16 Aug 2024 11:30 AM IST

Hyderabad: Aurobindo Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has issued a warning letter for...

Torrent Pharma net profit rises 30 percent to Rs 591 crore in Q2

Ipca Labs net profit up 18 percent to Rs 192 crore in Q1

Ruchika Sharma15 Aug 2024 1:30 PM IST

Mumbai: Ipca Laboratories has announced that its consolidated net profit for the first quarter ended June 30, 2024, rose by 18 percent to Rs 192...

AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITAT

AstraZeneca-Daiichi Sankyo Enhertu approved in China for patients with previously treated HER2-positive advanced or metastatic gastric cancer

Ruchika Sharma15 Aug 2024 10:30 AM IST

Cambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has received conditional approval in China as a monotherapy for...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Torrent Pharma is said to seek raising USD 3 billion for KKR stake in JB Chemicals: Report

Ruchika Sharma14 Aug 2024 4:30 PM IST

New York: Torrent Pharmaceuticals Ltd. is looking to raise as much as USD 3 billion from global banks to buy a controlling stake in JB Chemicals...

Natco Pharma net profit down 23.44 percent at Rs 517.9 crore in Q2

Natco Pharma net profit increases 59 percent to Rs 668 crore in Q1

Ruchika Sharma14 Aug 2024 3:32 PM IST

Hyderabad: Hyderabad-based NATCO Pharma Limited has recorded consolidated total revenue of Rs 1410.70 Crore for the first quarter ended on 30th...

Delhi Police Cracks Fake Drug Network, Counterfeit Ultracet, Augmentin Seized, 6 Held

Domestic API firms revenue to see 7-8 percent rise by 2029: Icra

Ruchika Sharma14 Aug 2024 2:30 PM IST

New Delhi: The revenue of domestic active pharmaceutical ingredient (API) manufacturing firms is projected to grow by 7-8 percent by 2029, according...

Novartis concludes acquisition of Tourmaline Bio

Entresto: Novartis loses initial bid to block generic of blockbuster heart drug

Ruchika Sharma14 Aug 2024 11:30 AM IST

London: Novartis, a leading pharmaceutical company, has failed in its attempt to convince a federal court to block MSN Pharmaceuticals, a generic...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok